Alpha Diagnostic International, Inc. Anti-Human Liver-expressed antimicrobial peptide 2 (LEAP2) Control/blocking peptide LEAP22-P

Anti-Human Liver-expressed antimicrobial peptide 2 (LEAP2) Control/blocking peptide General Information From human blood ultrafiltrate, a novel gene-encoded, cysteine-rich, and cationic peptide termed as liver-expressed antimicrobial peptide 2 (LEAP-2) together with several circulating forms of LEAP-2 differing in their amino-terminal length were identified SugApplications Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. SpeciesReactivity Human Form Antigen/blocking Peptide Antigen 20-aa peptide of Human LEAP-2 (Protein accession # Q969E1 ; ref. 1); designated as LEAP22-P control/blocking peptide conjugated to KLH; epitope location ~ C-terminus SpCrossreactivity Human LEAP22-P peptide sequence is 100% conserved in mouse and rat. Antibody cross-reactivity in various species is not known For research use only, not for diagnostic or therapeutic use.